Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer’s disease neuropathology: Preliminary observations

Abstract INTRODUCTION Down syndrome (DS) is caused by a complete or partial trisomy of chromosome 21, resulting in variable intellectual disabilities and a high risk for early-onset Alzheimer’s disease (DS-AD). Dysregulation of the mammalian target of rapamycin...

Multi‐omics identification of haptoglobin as a novel target for increased Alzheimer’s disease risk associated with obesity through inhibiting the phagocytosis of Aβ by disease‐associated microglia

Abstract INTRODUCTION Obesity may increase Alzheimer’s disease (AD) risk, yet the underlying mechanisms remain unclear. METHODS We investigated this link through global epidemiology, Mendelian randomization (MR), transcriptomics, clinical cohort validation, and...